Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
Business
Archived
•
July 16, 2026
•
2 views
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
Source: https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Retirement Health Care"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
